Retrospective study of monascus purpureus compound preparation in treating phlegm turbidity and blood stasis type primary dyslipidemia

Mengmei YIN,Hui YE,Shengli FENG,Xuezhi ZHANG
DOI: https://doi.org/10.3969/j.issn.2095-6606.2016.04.003
2016-01-01
Abstract:Objective To study the clinical effect of monascus purpureus compound preparation in trea-ting phlegm turbidity and blood stasis type primary dyslipidemia, thus to provide references for the diag-nosis and treatment of dyslipidemia. Methods Retrospective analysis was conducted on clinical data of 140 patients with phlegm turbidity and blood stasis type primary dyslipidemia from traditional Chinese medicine ( TCM) and integrated traditional Chinese and western medicine department in Peking universi-ty first hospital during December 2013—December 2015 . The changes of TCM syndrome score and lipid levels were analyzed after 1 month treatment. Results TCM syndrome score was improved after treat-ment. High-normal and high levels of total cholesterol (TC) were reduced by(11. 59 ± 12. 26)%, (22. 44 ± 11. 05)%,respectively. High-normal and high levels of low density lipoprotein cholesterol (LDL-C) were reduced by (18. 78 ± 15. 26)%、(27. 12 ± 15. 73)%,respectively. The falling degrees of high level TC and LDL-C were greater than that of high-normal levels. High level triglyceride( TG) was reduced by (22. 63 ± 27. 91)%. High density lipoprotein cholesterol (HDL-C) which was below normal before treatment increased after treatment. Conclusion Monascus purpureus compound preparation can improve TCM syndromes, decrease the content of TC, LDL-C and TG and increase HDL-C as well.
What problem does this paper attempt to address?